Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Sep 10, 2023 9:40pm
106 Views
Post# 35628671

RE:RE:RE:RE:RE:New article in La Presse this morning

RE:RE:RE:RE:RE:New article in La Presse this morning The blackout period is a real thing. Since insiders have inside info, they are not allowed to buy or sell when they are in possession of material info, which is most of the time. As you can imagine, these heavy constraints are also a disincentive to buy even when they can because you can easily get locked into holding when you might want to sell. Just look at the two exectives who have been forced to not exercise and sell their very low cost options. At one point not too long ago, those options were worth something but because THTX has apparently been in a blackout period since last December, they were never able to exercise those options. 

The blackout periods are not a silly excuse that corporate executives make up to avoid buying or selling their stock - they are real. The fact that they ahve apparently been blacked out all eyar is an indication that there is a lot going on at THTX and we are likely aware of only a small fraction of what that might have been and still is. 
PWIB123 wrote: The blackout period is just an excuse for their embarassing lack of buying.  Maybe they live too high on the hog and have no money.  Doesn't matter.  They completely missed the opportunity to show faith in the company and help stop the bleeding share price, take advantage of what they just admitted is a ridiculously low share price, and actually bring more investors to the table.  Why would they even mention a current black out period in a historical reference?  Where were they 30-60 days ago?  This also suggest that there's nothing else in the works that would have precluded them from buying before the financial reporting period began.  It still just blows me away how they don't seem to get it.


<< Previous
Bullboard Posts
Next >>